BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Auspex Genomics Launches a DNA Cancer Screen to Empower People to Understand Their Genetic Risk of Cancer on the Crowd Funding Site indiegogo.com


6/17/2013 8:59:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, California – June 17, 2013 - The Auspex Genomics DNA cancer screen provides information on your genetic risk of the most common types of cancers for the cost of your smartphone. Auspex Genomics provides a saliva sample collection kit that you mail back to us. Once your kit is received, we extract the DNA from your saliva and start the DNA sequencing process. With your variations determined, we translate your results into a personalized report. Our proactive informational tool shows you what genes you have, how they relate to cancer and if you have a variation in specific genes leading to an increased chance of cancer. You can use this information to make proactive changes such as wearing sunscreen and protective clothing if you have a variation linked to skin cancer or having more frequent exams if you have a variation linked to breast cancer.

We know that cancer is not something caught like the flu; it’s rooted deeper on a genetic level. Knowing your cancer genetics is valuable information that everyone should have access to. At $200 this is now possible.

Daniel Blake, co-founder of Auspex Genomics, said “Auspex Genomics was born when I couldn’t get the information I wanted when I was diagnosed with cancer. I wanted to see what my genetic blueprint could tell me so I could be treated in the most effective manner. Today we have accomplished this and more by providing people the opportunity to discover what their genetic blueprint can tell them about their cancer risk. Most importantly, anyone can do this from the comfort of their home and anytime they please.”

Auspex Genomics is a comprised of researchers with backgrounds in: super-computing, mathematics and organic chemistry. After a successful bout with cancer, Auspex Genomics founder switched the direction of his career from mathematics research and spent thefollowing six years researching cancer. Using a non-traditional approach, Auspex Genomics developed an innovate approach to genetic sequencing that drives down the cost of the technology while providing the highest available accuracy.

For media inquiries, contact Brian Wallace at 407-257-5949 or bwallace@auspexgenomics.com http://auspexgenomics.com/

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES